Reverse-Switch Of Stada’s Lemocin On The Agenda Of Germany's Switch Committee

Germany's Expert Committee for Prescription will consider the reverse-switch of tyrothricin – a key ingredient in Stada's recently-acquired Lemocin throat lozenge – to presciption-only status and the Rx-to-OTC switch of soluble fluoride tablets for the oral treatment of osteoporosis.

The question mark in a number of
• Source: Shutterstock

Head-scratchers seem to be the order of the day at the German switch committee’s next meeting on 26 January 2021.

Firstly, Germany’s Expert Committee for Prescription – an independent body that advises the country’s Ministry of Health, the BMG, on reclassifications – will consider the reverse-switch of tyrothricin for the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Rx-to-OTC Switch

More from Health